Literature DB >> 15609323

Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.

Johanne Leroy-Dudal1, Christine Demeilliers, Olivier Gallet, Emmanuel Pauthe, Soizic Dutoit, Rémy Agniel, Pascal Gauduchon, Franck Carreiras.   

Abstract

The growth of ovarian carcinoma is dependent upon their vascularistion, but the interaction of ovarian cancer cells with the endothelium and their invasion through an endothelial environment remain poorly understood at the molecular level. To investigate adhesive events underlying this process with focusing on the role of alphav integrins and MT1MMP-MMP2 proteinases, we used in vitro models of cocultures of human ovarian adenocarcinoma cell lines (IGROV1 and SKOV3) with human umbilical vein endothelial cells (HUVECs). Immunostaining of HUVECs revealed the network organisation of fibrillar fibronectin (Fn) and pericellular vitronectin (Vn). During coculture, IGROV1 and SKOV3 cells gain access to subendothelial basement membrane of HUVECs and dislocated endothelial Fn without affecting endothelial Vn. Transmigration assays revealed that tumour cells invade Vn and, with an higher efficiency, Fn. Our data also highlighted that ovarian carcinoma cells migrated through the Fn-rich HUVEC-ECM. The expression of MMP2 and MT1-MMP was revealed in tumour cells within an endothelial environment. Furthermore, we found that cell migration through the endothelial ECM was almost totally dependent on alphav integrin function, whereas beta1 integrins were not solicited. In addition, inhibitors of MMP2 activity (alone or combined with anti-alphav integrin MAb) or TSRI265 (which blocks MMP2-alphavbeta3 association) were found to impede this process. Finally, alphav integrins, MT1-MMP and MMP2 were found in ovarian carcinoma cells within the 3-dimensional architecture of intraperitoneal tumour nodes collected from nude mice xenografted with IGROV1 or SKOV3 cell lines or within human tumour tissues. alphav integrins therefore appear as essential to the migration properties of human ovarian carcinoma cells, especially in an endothelial environment, with MMP2 participating to this process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15609323     DOI: 10.1002/ijc.20778

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.

Authors:  Tobias Engl; Borna Relja; Dana Marian; Christa Blumenberg; Iris Müller; Wolf-Dietrich Beecken; Jon Jones; Eva M Ringel; Jürgen Bereiter-Hahn; Dietger Jonas; Roman A Blaheta
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

2.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

3.  Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study.

Authors:  Paul A Rupp; Richard P Visconti; András Czirók; David A Cheresh; Charles D Little
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

4.  Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

Authors:  Sabrina Kellouche; Julien Fernandes; Johanne Leroy-Dudal; Olivier Gallet; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2010-02-24

5.  Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces.

Authors:  Claudia Tanja Mierke; Benjamin Frey; Martina Fellner; Martin Herrmann; Ben Fabry
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

6.  In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis.

Authors:  Rachel A Davidowitz; Marcin P Iwanicki; Joan S Brugge
Journal:  J Vis Exp       Date:  2012-02-17       Impact factor: 1.355

7.  Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.

Authors:  Eva Juengel; Jasmina Makarević; Michael Reiter; Jens Mani; Igor Tsaur; Georg Bartsch; Axel Haferkamp; Roman A Blaheta
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

8.  Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Authors:  Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David Tice; Anil K Sood
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.

Authors:  Galina Gritsina; Fang Xiao; Shane W O'Brien; Rashid Gabbasov; Marisa A Maglaty; Ren-Huan Xu; Roshan J Thapa; Yan Zhou; Emmanuelle Nicolas; Samuel Litwin; Siddharth Balachandran; Luis J Sigal; Dennis Huszar; Denise C Connolly
Journal:  Mol Cancer Ther       Date:  2015-02-02       Impact factor: 6.261

10.  The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.

Authors:  Zhen Lu; Robert C Bast
Journal:  Cell Adh Migr       Date:  2013-01-28       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.